Eosinophilic Granulomatosis with Polyangiitis
📧 Sign up to get email alerts when something new happens for Eosinophilic Granulomatosis with Polyangiitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment [Phase 3]
Phase 3 rollover trial to continue benralizumab (Fasenra) in participants who completed a prior study and benefited from treatment; not yet …
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: NUCALA® Special Drug Use Investigation (EGPA, Long-term)
This clinical trial update reports the completion and posting of long-term results for the NUCALA Special Drug Use Investigation in eosinoph…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis [Phase 2]
A Phase 2 clinical trial evaluating low-dose naltrexone for improving physical health in patients with vasculitis has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: One-Time DNA Study for Vasculitis
A University of Pennsylvania-led trial is recruiting for a one-time DNA study of various vasculitides, including eosinophilic granulomatosis…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Rituximab in Eosinophilic Granulomatosis With Polyangiitis [Phase 3]
Phase 3 trial update reporting completion of a study evaluating rituximab for eosinophilic granulomatosis with polyangiitis (EGPA).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis. [Phase 3]
Phase 3 trial comparing rituximab to azathioprine for maintaining remission in eosinophilic granulomatosis with polyangiitis (EGPA) has comp…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome) [Phase 3]
A Phase 3 trial evaluated adding azathioprine to corticosteroids in microscopic polyangiitis, polyarteritis nodosa, or eosinophilic granulom…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma
A completed study from Queen Mary University of London investigates autoantigens in eosinophilic granulomatosis with polyangiitis (Churg-Str…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab. [Phase 3]
Phase 3 head-to-head trial evaluating efficacy and safety of benralizumab versus mepolizumab in eosinophilic granulomatosis with polyangiiti…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan
A long-term real-world study of mepolizumab for eosinophilic granulomatosis with polyangiitis (Churg–Strauss) in Japan has completed with re…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Hydroxychloroquine in ANCA Vasculitis Evaluation [Phase 4]
Phase 4 trial update evaluating hydroxychloroquine for ANCA-associated vasculitis, including microscopic polyangiitis, eosinophilic granulom…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis [Phase 2]
Phase 2 clinical trial investigating tezepelumab for eosinophilic granulomatosis with polyangiitis (EGPA) to evaluate efficacy and mechanism…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921 [Phase 3]
Phase 3 long-term access program update for mepolizumab in subjects from a prior study; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study [Phase 2]
Phase 2 trial evaluating benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA) in patients with asthma; current status is un…
-
CLINICAL_TRIALS trial_result · 2018-01-26Clinical Trial Update: A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis [Phase 3]
A Phase 3 trial evaluating mepolizumab for eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) has completed; results wer…
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study [Phase 2]
Phase 2 clinical trial update for reslizumab in eosinophilic granulomatosis with polyangiitis (EGPA) related asthma.
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome [EARLY_Phase 1]
A Phase 1 trial evaluating immuno-ablation with chemoimmunoradiation and autologous stem cell transplant for eosinophilic granulomatosis wit…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: The ANCA Vasculitis Questionnaire (AAV-PRO©)
The ANCA Vasculitis Questionnaire (AAV-PRO©) trial update notes that the study evaluating a patient-reported outcome instrument for ANCA-ass…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome [Phase 1, Phase 2]
Mepolizumab is being studied as a steroid-sparing treatment option for eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Vasculitis Illness Perception (VIP) Study
The Vasculitis Illness Perception (VIP) study has completed. The update lists several vasculitis conditions studied, including granulomatosi…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Reproductive Health in Men and Women With Vasculitis
A completed clinical trial evaluating reproductive health in men and women with various forms of vasculitis.
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Rituxan in Churg Strauss Syndrome With Renal Involvement [Phase 2]
A Phase 2 trial of rituximab for eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) with renal involvement was terminate…
-
CLINICAL_TRIALS trial_result · 2011-09-12Clinical Trial Update: Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years [Phase 4]
A Phase 4 clinical trial update from Assistance Publique - Hôpitaux de Paris evaluating treatment for necrotizing vasculitides in patients a…
-
CLINICAL_TRIALS trial_result · 2007-11-19Clinical Trial Update: RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides [NA]
This completed trial compared infliximab versus rituximab in systemic necrotizing vasculitides, including granulomatosis with polyangiitis, …